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Abstract
Background: Mycoplasma genitalium is an emerging sexually transmitted pathogen that has been
associated with significant reproductive tract inflammatory syndromes in women. In addition, the strong
association between severity of M. genitalium infection and Human Immunodeficiency Virus type 1 (HIV-
1) shedding from the cervix suggests that innate responses to M. genitalium may influence pathogenesis of
other sexually transmitted infections. Epithelial cells (ECs) of the reproductive mucosa are the first cells
contacted by sexually transmitted pathogens. Therefore, we first characterized the dynamics of
intracellular and extracellular localization and resultant innate immune responses from human vaginal,
ecto- and endocervical ECs to M. genitalium type strain G37 and a low-pass contemporary isolate, M2300.
Results: Both M. genitalium strains rapidly attached to vaginal and cervical ECs by 2 h post-infection (PI).
By 3 h PI, M. genitalium organisms also were found in intracellular membrane-bound vacuoles of which
approximately 60% were adjacent to the nucleus. Egress of M. genitalium from infected ECs into the culture
supernatant was observed but, after invasion, viable intracellular titers were significantly higher than
extracellular titers at 24 and 48 h PI. All of the tested cell types responded by secreting significant levels
of pro-inflammatory cytokines and chemokines in a pattern consistent with recruitment and stimulation
of monocytes and macrophages. Based on the elaborated cytokines, we next investigated the cellular
interaction of M. genitalium with human monocyte-derived macrophages and characterized the resultant
cytokine responses. Macrophages rapidly phagocytosed M. genitalium resulting in a loss of bacterial viability
and a potent pro-inflammatory response that included significant secretion of IL-6 and other cytokines
associated with enhanced HIV-1 replication. The macrophage-stimulating capacity of M. genitalium was
independent of bacterial viability but was sensitive to heat denaturation and proteinase-K digestion
suggesting that M. genitalium protein components are the predominant mediators of inflammation.
Conclusion: Collectively, the data indicated that human genital ECs were susceptible and immunologically
responsive to M. genitalium infection that likely induced cellular immune responses. Although macrophage
phagocytosis was an effective method for M. genitalium killing, intracellular localization within vaginal and
cervical ECs may provide M. genitalium a survival niche and protection from cellular immune responses
thereby facilitating the establishment and maintenance of reproductive tract infection.
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Mycoplasma genitalium is now recognized as a sexually
transmitted pathogen [1,2]. In healthy young men and
women, the prevalence of M. genitalium infection is
approximately 1% and is between those of gonococcal
(0.4%) and Chlamydia trachomatis (4.2%) infections [2].
In men, M. genitalium is a recognized and important cause
of non-gonococcal urethritis [3]. Reproductive tract dis-
ease syndromes associated with M. genitalium infection in
women include pelvic inflammatory disease [4] and cerv-
icitis [5-9]. Limited serologic studies and detection of M.
genitalium DNA in cervical, endometrial and/or Fallopian
tube specimens from women with salpingitis [10] have
suggested that M. genitalium could also be a cause of tubal
factor infertility [11,12] independent of Chlamydia tracho-
matis. Importantly, the burden of M. genitalium at the cer-
vical mucosa is positively correlated with Human
Immunodeficiency Virus type 1 (HIV-1) shedding [13]
but the cell types involved and the mechanisms of these
associations remain unclear. Select pro-inflammatory
cytokines, including IL-6, have been associated with
increased HIV-1 titers [14] and up-regulate HIV-1 replica-
tion [15]. These findings indicate that M. genitalium infec-
tion may enhance acquisition or dissemination of other
sexually transmitted infections and provide strong ration-
ale for investigation into the host innate immune
response.
The mucosal surfaces of the female reproductive tract pro-
vide a physical barrier against invading pathogens. Impor-
tantly, these surfaces are adapted to constant antigenic
stimulation from the normal polymicrobial flora but are
concomitantly charged with recognition and response to
pathogen exposure. Following sexual transmission, M.
genitalium and other pathogens make initial contact with
epithelial cells (ECs) that play an important role in early
activation of the innate response. ECs of the vagina and
cervix express robust levels of Toll-like receptor (TLR) 2, 3,
5, 6 and CD14 with low levels of TLR1, 4 and 7–9 [16].
Furthermore, both vaginal and cervical ECs recognize bac-
terial ligands via TLR2/6 such as the macrophage-activat-
ing lipopeptide of Mycoplasma fermentans [17]. Although
macrophages are not always resident in the vaginal
lumen, they are distributed throughout the epithelial and
sub-epithelial mucosa of the vagina and cervix and make
up a significant proportion of the total immune cell pop-
ulation of the reproductive tract [18]. Generally, macro-
phages recognize, phagocytose and destroy pathogenic
bacteria [19] and studies are needed to address directly the
interaction of M. genitalium with human macrophages.
Specifically, it currently is unclear whether infection of
reproductive tract ECs elicits chemokine secretion for
recruitment of phagocytic cells to infected tissues resulting
in inflammation.
Lipoprotein-enriched detergent phase preparations from
M. genitalium strain G37 have been reported to activate
inflammatory cytokine secretion from a transformed
monocytic cell line [20,21] but these fractions have yet to
be tested using human genital ECs or cell types more rele-
vant to genital transmission. Recently, our group has
shown that human reproductive tract ECs are highly
responsive to TLR2/6-activating regions of the MG309-
encoded protein resulting in inflammatory cytokine secre-
tion [22]. To further explore the responses of human gen-
ital ECs, we have established that M. genitalium
inoculation of human vaginal, ecto- and endocervical ECs
results in both extra- and intracellular infection that elicits
tissue-specific cytokine secretion. The elaborated
cytokines were consistent with recruitment of macro-
phages to the reproductive mucosa. In addition, subse-
quent testing showed that human monocyte-derived
macrophages (MDM) rapidly phagocytosed and killed M.
genitalium resulting in a robust secretion of pro-inflamma-
tory cytokines. These data provide the first characteriza-
tion of the human innate immune response to viable M.
genitalium from relevant cell types of the female reproduc-
tive tract and provide insight into the dynamic interaction
with the reproductive mucosa.
Methods
Human cell culture
Immortalized human ECs derived from vaginal (n = 3
donors; V19I, V12I, V11I), ectocervical and endocervical
tissues were maintained as described previously [16].
Keratinocyte serum-free medium (KSFM; Invitrogen,
Carlsbad, CA) supplemented with bovine pituitary extract
(50 mg/L), recombinant epidermal growth factor (5 ug/
L), CaCl2 (44.1 mg/L), penicillin-G (100 U/mL) and strep-
tomycin sulfate (100 ug/mL) was used for culture of
ectocervical and endocervical ECs at 37°C in a 5% CO2
humidified incubator [23]. Vaginal ECs were maintained
in a 1:1 mixture of KSFM and VEC-100 media (MatTek,
Ashland, MA). ME-180 (ATCC HTB-33) cervical carci-
noma cells were maintained in RPMI 1640 (MediaTech,
Herndon, VA) medium supplemented with 0.1 mM non-
essential amino acids (Sigma-Aldrich, St. Louis, MO), 2
mM L-glutamine, penicillin-G (100 U/mL), streptomycin
sulfate (100 ug/mL) and 10% fetal bovine serum (FBS;
Invitrogen). Cells were verified to be free of any contami-
nating mycoplasmas by PCR (Stratagene, Cedar Creek,
Texas).
Propagation of M. genitalium strains G37 and M2300
Mycoplasma genitalium type strain G37 (ATCC 33530) or
the more contemporary, lower passage Danish M2300
strain was propagated in Friis FB medium [24]. Briefly, M.
genitalium stocks (stored at -80°C) were inoculated asep-
tically into tightly sealed tissue culture flasks containingPage 2 of 11
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for 5–8 d. Growth was monitored by the formation of
adherent microcolonies and a pH-mediated color change
of the medium. M. genitalium was harvested from culture
flasks by pouring off the spent medium, extensively wash-
ing adherent mycoplasmas with 5 volumes of approxi-
mately 5 mL each of sterile PBS and then scraping
adherent microcolonies into fresh PBS. M. genitalium via-
bility was quantified in 96-well plates by serial 10-fold
dilution of each sample into fresh Friis FB medium. The
last dilution to show a change in color and formation of
microcolonies was used to calculate the approximate
number of viable organisms in the original sample. UV-
inactivation (254 nm) of M. genitalium was performed
using a Stratalinker 2400 (Stratagene, La Jolla, CA) to a
total energy of 720,000 microjoules/cm2. Heat denatura-
tion of M. genitalium was accomplished by incubating log-
phase cultures at 80°C for 15 min and then rapid cooling
on ice. Loss of viability was verified by an absence of
growth in Friis FB medium after 14d incubation at 37°C.
Isolation of human monocyte-derived macrophages
Human macrophages were generated as described previ-
ously [25] from peripheral blood mononuclear cells
(PBMC) collected from healthy volunteers with Univer-
sity of Texas Medical Branch Institutional Review Board
approval. Briefly, PBMCs were isolated using Hypaque-
Ficoll (Amersham Biosciences, Piscataway, NJ) density-
gradient separation. Selection was performed using the
magnetic column separation system (StemCell Technolo-
gies, Vancouver, Canada). Purified monocytes were differ-
entiated into macrophages by culturing in RPMI 1640
medium supplemented with 10% FBS, L-glutamine,
HEPES, sodium pyruvate and GM- CSF (100 ng/mL). Fol-
lowing 7d of differentiation, monocyte-derived macro-
phages (MDM) were removed from the culture plastic
using a non-enzymatic cell dissociation solution (cat #
C1544, Sigma-Aldrich) and then resuspended in fresh
RPMI 1640 medium. Macrophage differentiation was ver-
ified by flow cytometric confirmation of CD11b, CD80
and CD86 expression showing typical purities of >95%
(data not shown). Macrophages were differentiated from
PBMCs collected from 3 different blood donors and used
in 3 independent experiments.
Electron Microscopy
I. Transmission electron microscopy
Adherent monolayers of M. genitalium-inoculated (G37 or
M2300; MOI 100) or non-inoculated genital ECs or
human MDM (MOI 100) were fixed at indicated times
from 2–48 h post-infection (PI) in a mixture of 2.5% for-
maldehyde and 0.1% glutaraldehyde in 0.05 M cacodylate
buffer (pH 7.2) containing 0.03% trinitrophenol and
0.03% CaCl2. Cells were scraped, centrifuged briefly at
1,000 × g, washed in 0.1 M cacodylate buffer (pH 7.2) and
then post-fixed in 1% OsO4 in the same buffer. Each sam-
ple was stained en bloc with 1% uranyl acetate in 0.1 M
maleate buffer, dehydrated in ethanol and embedded in
Poly/Bed 812 epoxy resin (Polysciences, Warrington, PA).
Ultrathin sections were cut using the Ultracut S ultrami-
crotome (Reichert-Leica). Sections were stained sequen-
tially in 2% aqueous uranyl acetate and lead citrate and
then examined in a Philips 201 or CM 100 electron micro-
scope at 60 kV.
II. Scanning electron microscopy
M. genitalium-infected and non-infected control cells were
fixed as described above for transmission electron micro-
scopy (TEM) for at least 1 h at room temperature, post-
fixed in 1% OsO4 in 0.1 M cacodylate buffer, dehydrated
in ethanol, treated with hexamethyldisalazane and then
air dried. Next, the coverslips were mounted on the speci-
men stubs and sputter coated with iridium for 40 sec in an
Emitech K575X turbo sputter coater (Emitech, Houston,
TX). Samples were examined in a Hitachi S4700 field
emission scanning electron microscope (Hitachi High
Technologies America, Electron Microscope Division,
Pleasanton, CA) at 2 kV.
Quantification of M. genitalium uptake by cervical 
epithelial cells
Uptake of M. genitalium by reproductive tract ECs was
assessed using the gentamicin invasion assay [26]. The
sensitivity of M. genitalium strains G37 and M2300 to gen-
tamicin was established first by inoculation of log-phase
organisms into Friis FB medium with gentamicin concen-
trations ranging from 100–400 ug/mL. No M. genitalium
growth was observed at 200 or 400 ug/mL therefore a
working concentration of 200 ug/mL was employed in
subsequent studies to minimize EC uptake of gentamicin
and subsequent killing of intracellular M. genitalium. Con-
firmatory studies were completed subsequently using 400
ug/mL gentamicin. As a representative genital EC type,
ME-180 cells were seeded into 96-well plates 1d prior to
infection at a density of 1 × 105 cells/well. Log-phase M.
genitalium was inoculated onto ME-180 cells (MOI of
100) in triplicate. Following 3 h incubation, when M. gen-
italium appeared to be attached to and invading genital
ECs (see Figure 1), the inoculum was removed and
replaced with fresh medium containing gentamicin. At 15
min, 24 and 48 h following removal of the inoculum, cul-
ture supernatants were removed and the infected cells
were washed 3× with sterile PBS. Cells then were removed
from the well by scraping into Friis FB medium followed
by plating serial 10-fold dilutions prepared in Friis FB
medium into a 96-well plate. Outgrowth of M. genitalium
from infected ME-180 cells was observed for 14d. The
load of viable M. genitalium from each sample was calcu-
lated by titration as described above.
The gentamicin invasion assay also was utilized to inves-
tigate whether intracellular M. genitalium were able toPage 3 of 11
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180 cervical ECs were infected with M. genitalium and
then extracellular organisms were killed with gentamicin
(2 h) after 3 h of infection as described above. Infected
ECs then were rinsed 3× with PBS and overlaid with fresh
medium that did not contain gentamicin. At 15 min, 24
and 48 h following removal of the gentamicin, culture
supernatants were collected for quantification of M. geni-
talium that had egressed from the infected cells. Quantifi-
cation was performed in triplicate experiments using the
CCU assay as described above.
Stimulation of genital epithelial cells or primary 
monocyte-derived macrophages
Human vaginal, ectocervical or endocervical ECs were
seeded into 96-well plates at a density of 1 × 105 cells/well.
Primary human MDM were seeded into 96-well plates at
5 × 104/well. Following overnight incubation at 37°C,
Cultivation of M. genitalium and ultrastructural analysis of attachment to vaginal epithelial cellsFigure 1
Cultivation of M. genitalium and ultrastructural analysis of attachment to vaginal epithelial cells. M. genitalium 
G37 or M2300 were grown to log-phase in Friis FB medium. (A) Light micrograph of attached G37 microcolonies grown in cul-
ture flasks containing Friis FB medium taken using Variable Relief Contrast (VAREL). (B) TEM micrograph of a single G37 
microcolony after 3d growth in Friis FB medium showing highly variable size and morphology. (C) Within M. genitalium G37 
microcolonies, an elongated tip-like structure (arrow) was observed. (D) TEM micrograph M. genitalium strain M2300 showing 
similar variable morphology compared to G37 and formation of an electron-dense tip structure. Log-phase M. genitalium were 
harvested from Friis medium and then inoculated onto vaginal EC monolayers for ultrastructural analysis of attachment. (E) 
SEM micrograph of M. genitalium G37 attached to vaginal ECs (2 h PI). (F) TEM micrograph of M. genitalium G37 attached to 
vaginal ECs collected 3 h PI. An electron dense core structure presumably involved in attachment and invasion of vaginal ECs is 
highlighted by the oval. Similar electron dense cores were observed in some tip structures and can be seen in panel C.Page 4 of 11
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fresh medium to remove any constitutively secreted
cytokines. Log-phase M. genitalium G37 or M2300 was
harvested as described above, re-suspended in fresh PBS
and then inoculated onto each cell type (MOI of 10).
Controls for innate immune stimulation included the M.
salivarium-derived TLR2/6 agonist, FSL-1 (0.1 ug/well) or
an equal volume of the PBS vehicle added to triplicate
wells and processed in parallel. Secreted cytokines were
quantified from culture supernatants 6 or 48 h PI via a
cytometric bead array (CBA) assay using the human 27-
Plex panel of cytokine targets (Bio-Rad Laboratories, Her-
cules, CA). For testing of M. genitalium viability following
macrophage exposure, infected macrophages were inocu-
lated into Friis FB medium 30 min, 2, 6 or 12 h PI and
observed for M. genitalium outgrowth indicated by a pH-
mediated color change and adherent microcolony forma-
tion.
Statistical Analyses
The Student's t test was used to calculate significant differ-
ences in intra- and extracellular M. genitalium titers and
when comparing secretion of individual cytokines from a
single cell type to basal (PBS-treated) levels. The one-way
ANOVA followed by Dunnett's post-test (Prism v. 4.0,
GraphPad, San Diego, CA) was used to calculate signifi-
cant differences in cytokine secretion levels when more
than 2 conditions were compared. Significance was indi-
cated when p < 0.05.
Results
M. genitalium ultrastructure, attachment and invasion of 
human genital epithelial cells
M. genitalium strain G37 or M2300 grown to log phase in
Friis medium resulted in adherent microcolony formation
and were characterized by a radial gradient of colony
diameter (Figure 1A). Within each microcolony, M. geni-
talium organisms were densely packed and highly pleo-
morphic (Figure 1B). Several organisms were observed
that showed a tip-like structure (noted with arrows) for
both the Danish M2300 strain (Figure 1C) and G37 (Fig-
ure 1D).
M. genitalium has been shown previously to occupy intra-
cellular spaces in cultured cells of non-reproductive origin
[27-29] and cells obtained clinically from vaginal swabs
of M. genitalium-positive women [30]. However, the inva-
sion dynamics for genital cell types are not well under-
stood. Inoculation of genital ECs with M. genitalium
strains G37 or M2300 (MOI 100 for electron microscopy)
resulted in attachment to vaginal (V19I; Fig 1E) and cervi-
cal (ME-180; data not shown) ECs by 2 h PI. Attachment
of M. genitalium G37 and M2300 to reproductive tract ECs
was consistently characterized by a polarized electron-
dense core, within the M. genitalium organism [31], seen
adjacent to the host cell membrane (core indicated in Fig-
ure 1F). This dense core was evident within some tip struc-
tures as shown for M2300 (Figure 1C). After 3 h infection,
M. genitalium G37 were attached to the host cells (Figure
2; starred arrows) and also observed in intracellular vacu-
oles distributed throughout the cellular cytosol (Figure 2;
arrows). In approximately 60% of examined cells, intrac-
ellular vacuoles were directly adjacent to the nucleus (N;
Figure 2). Similar findings were observed 6–48 h PI (data
not shown) for both the G37 and M2300 strain. At these
later time points, extracellular M. genitalium also were
observed but were often in aggregates and showed no evi-
dence of attachment or invasion of host cells. Morpholog-
ically, the intracellular and extracellular mycoplasmas
were highly pleomorphic and appeared to have normal
ultrastructure indicated by a dense content of ribosomes
and few degraded bacterial membranes. A previously
Attachment and invasion of vaginal epithelial cells by M. geni-taliumFigure 2
Attachment and invasion of vaginal epithelial cells by 
M. genitalium. M. genitalium G37 or M2300 were harvested 
from log-phase cultures in Friis FB medium and then inocu-
lated onto vaginal ECs. After 3 h of infection, cells were fixed 
and processed for TEM imaging. Many M. genitalium organ-
isms were attached to the host cell surface associated with a 
polarized electron-dense core structure (starred arrow). In 
addition, M. genitalium organisms were localized to intracellu-
lar vacuoles (arrows) distributed throughout the cellular 
cytosol. Approximately 60% of observed vaginal ECs showed 
intracellular vacuoles directly adjacent to the nucleus 
(denoted as N). Similar findings were observed in cervical 
ECs and for the Danish M2300 strain.Page 5 of 11
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genitalium grown in Friis FB medium (Figure 1C and 1D)
but an elongated tip structure was not always visible on
mycoplasmas attached to host cells in each stained sec-
tion. No similar organisms or structures were observed in
non-infected cells processed in parallel.
We next quantified M. genitalium G37 and M2300 viabil-
ity from intra- and extracellular fractions of cultured ME-
180 cells using a gentamicin protection assay as described
in the Methods. To quantify intracellular titers, the M. gen-
italium inoculum was incubated for 3 h to allow attach-
ment to and entry of host cells (See Figure 1) followed by
removal of the inoculum and replacement of fresh culture
medium containing a bactericidal concentration of gen-
tamicin (200 ug/mL). Fifteen minutes following inocula-
tion with either G37 or M2300 (Figure 3), no viable M.
genitalium were detected in the cells (data not shown).
Using a color changing unit assay (CCU), high titers of
viable intracellular M. genitalium were detected at both 24
h (not shown) and 48 h PI (Figure 3). No M. genitalium
viability was detected in supernatants containing gen-
tamicin at either point indicating that the observed titers
were due exclusively to intracellular mycoplasmas that
were protected from gentamicin exposure. Extracellular
M. genitalium titers, representing organisms that had
escaped from infected cells, were quantified from separate
wells using supernatants of infected cells. Extracellular tit-
ers from culture supernatants (dashed line) were signifi-
cantly less than intracellular titers (p < 0.05) at the tested
time points (48 h shown in Figure 3). These data indicated
that, after M. genitalium entry of the cell, more organisms
remained inside the cell than egressed to the culture
supernatant. Intracellular localization of M. genitalium in
vaginal and cervical ECs also was consistent with electron
microscopic analyses (Figure 1 and 2).
M. genitalium elicited pro-inflammatory cytokines from 
genital epithelial cells
Following demonstration of intracellular localization
within reproductive tract ECs, we evaluated the host
cytokine response from 3 human vaginal (V11I, V12I, and
V19I) and 2 cervical EC lines (sA2EN and 3ECI) [16]. Of
the tested time points, peak cytokine values were obtained
48 h PI and are presented in Table 1. Vaginal ECs exposed
to viable M. genitalium G37 or M2300 (MOI 10)
responded with significant secretion of interleukin-6 (IL-
6), IL-8 and GM-CSF (p < 0.05 vs. PBS control). Following
M. genitalium exposure, ectocervical ECs secreted signifi-
cant levels of IL-6 and IL-8 (p < 0.05 vs. PBS control).
Endocervical ECs responded to M. genitalium with the
most number of secreted cytokines that included IL-6, IL-
8, G-CSF, GM-CSF and MCP-1 (p < 0.05 vs. PBS control).
Using IL-8 secretion at 48 h PI as a comparator for all cell
types, endocervical ECs were more responsive than vagi-
nal or ectocervical cells when the fold increase of cytokine
secretion by infected cells was calculated and compared to
cells that received only PBS (ANOVA; p < 0.01, data not
shown). A similar pattern of cytokine elaboration was
observed following inoculation of M. genitalium at a MOI
of 1 (data not shown). Cytokines that were not signifi-
cantly induced by M. genitalium G37 or M2300 in any gen-
ital EC type included IL1-b, IL-2, IL-4, IL-5, IL-7, IL-9, IL-
10, IL-12(p40), IL-12(p70), IL-13, IL-15, IL-17, MIP1-a,
MIP1-b, Basic FGF, Eotaxin, IP-10, PDGF-BB and VEG-F.
The pattern of cytokines elaborated from cervical ECs was
consistent with monocyte and macrophage recruitment
and thus we next evaluated the responses of primary
human MDM to M. genitalium exposure and determined
Intra- and extracellular localization of M. genitalium in ME-180 cervic l epithelial ce lsFigure 3
Intra- and extracellular localization of M. genitalium 
in ME-180 cervical epithelial cells. Cervical ECs (ME-
180) were inoculated with log-phase cultures of M. genitalium 
strain G37 (A) or M2300 (B) to determine whether M. geni-
talium can invade human reproductive tract ECs. To quantify 
intracellular M. genitalium loads (solid bar), the inoculum was 
removed following 3 h incubation for attachment and entry 
and replaced with medium containing gentamicin (200 ug/
mL). The ability for M. genitalium to escape infected ECs 
(open bar) was quantified from culture supernatants in sepa-
rate wells processed the same way except, following the 3 h 
incubation, the inoculum was removed and extracellular M. 
genitalium organisms were killed with gentamicin (2 h expo-
sure). Infected cells then were washed thoroughly and 
received fresh medium without gentamicin allowing escaping 
M. genitalium to survive. Cell fractions or culture superna-
tants were collected at 48 h following removal of the inocu-
lum for quantification of bacterial loads using a color changing 
unit (CCU) assay. In every case, significant differences 
between intracellular and extracellular M. genitalium titers 
were observed (p < 0.05; Student's t-test). Parallel studies 
were performed that employed 400 ug/mL gentamicin with 
similar results (data not shown).Page 6 of 11
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cytosis and killing.
Phagocytosis of M. genitalium by human monocyte-
derived macrophages
To determine the susceptibility of M. genitalium to macro-
phage phagocytosis, human MDM were exposed to log-
phase M. genitalium strains G37 or M2300 (MOI 100) and
processed at selected time points for TEM. Within 5 min
of inoculation, M. genitalium appeared dark staining with
a dense content of ribosomes and no signs of membrane
degeneration (Figure 4A). As early as 30 min PI, M. geni-
talium uptake by MDM was observed that was associated
with morphologic changes of the bacterium including a
loss of ribosome density and a hollow appearance (Figure
4B) consistent with a loss of viability. Internalized M. gen-
italium were prevalent and localized to membrane-bound
phagolysosomes. Similar morphological changes were
observed 2 h PI (data not shown). By 6 h PI, the macro-
phages appeared to have many phagocytic vesicles but no
intracellular organisms could be located (Figure 4C). Via-
bility of M. genitalium following macrophage exposure
was evaluated by seeding infected MDM (6 h PI) into Friis
FB medium at 37°C. These cultures were observed for M.
genitalium outgrowth by a pH-mediated color change and
microcolony formation. No growth was detected over a
14d period from any of these cultures collectively indicat-
ing that M. genitalium was susceptible to rapid phagocyto-
sis and killing.
M. genitalium elicited pro-inflammatory cytokines from 
human monocyte-derived macrophages
Because M. genitalium was phagocytosed rapidly by
human MDM with no evidence of bacterial viability by 6
h PI, we sought to determine whether M. genitalium expo-
sure to human MDM would elicit acute-phase cytokine
responses. Viable M. genitalium G37 and M2300 inocu-
lated at MOI 10 or MOI 1 elicited significant cytokine
elaboration from macrophage cultures measured from
supernatants collected 6 h PI (G37 [MOI 10] results pre-
sented in Table 2). No significant differences were
observed between G37 and M2300 (data not shown). The
profile of induced cytokine responses from human mac-
rophages was composed predominately of early pro-
inflammatory markers including significant secretion of
IL-1β, TNF-α, IL-6, IL-8, G-CSF, IFN-γ, MCP-1, MIP-1α,
MIP-1β and RANTES (p < 0.05; Table 2). These findings
were consistent with results from 2 additional blood
donors (data not shown). Following UV inactivation, M.
genitalium elicited a similar profile and magnitude of
cytokine secretion (Table 2) indicating that the immunos-
timulatory capacity was not dependent upon bacterial via-
bility. Immune markers that were not induced by M.
genitalium in human MDM included IL-2, IL-4, IL-5, IL-7,
IL-9, IL-12(p70), IL-13, IL-15, IL-17, Basic FGF, Eotaxin,
IP-10, PDGF-BB and VEG-F. Considering IL-6, a represent-
ative acute-phase cytokine with a central role in innate
responses to bacterial pathogens [32], heat denaturation
or proteinase-K digestion of M. genitalium significantly
reduced the inflammatory capacity from human macro-
phages (Figure 5) suggesting that a significant proportion
of the inflammatory capacity was mediated by M. genital-
ium protein components.
Discussion
Considering that M. genitalium reproductive tract infec-
tions in humans [1,33] and non-human primates [34] are
often persistent, it seems likely that M. genitalium employs
some tactic(s) to elude the host response to establish
infection. Consistent with this hypothesis, attachment to
and invasion of vaginal and cervical ECs by M. genitalium
strains G37 and M2300 was observed by a subset of
organisms as early as 2 h PI (Figure 1) suggesting that
intracellular localization could provide a survival niche.
The intracellular M. genitalium organisms were found in
intracellular vacuoles similar in appearance to those seen
in cultured Vero [27], HeLa and EM42 cells [35]. Approx-
imately 60% of M. genitalium-containing vacuoles were







MOI 10 PBS MOI 10 PBS MOI 10 PBS
IL-6 127 ± 13.1* 69 ± 1.7 63.7 ± 1.8* 21.3 ± 2.4 348 ± 13* 196 ± 15
IL-8 1458 ± 117* 785 ± 11.3 3304 ± 300* 722 ± 98 5e7 ± 1347* 6e4 ± 367
G-CSF 261 ± 46 227 ± 37 548 ± 143 779 ± 122 155 ± 6.2* 93 ± 21
GM-CSF 24 ± 1.8* 8 ± 3.1 16 ± 2.6 10 ± 1.0 160 ± 9.4* 45 ± 12
MCP-1 5.8 ± 1.4 7 ± 2.1 11.4 ± 1.3 10 ± 3.1 7.2 ± 1.1* 0.46 ± 0.02
aHuman vaginal (n = 3 donors), ectocervical or endocervical ECs were inoculated with M. genitalium G37 (MOI 10). An equal volume of the PBS 
vehicle was added and processed in parallel as a control. Culture supernatants were collected 48 h PI to quantify secreted cytokines. Values are 
expressed as the mean ± SEM pg/mL from triplicate wells. Cytokine elaboration pattern and magnitudes induced following exposure to strain 
M2300 were not significantly different than G37. PBS values are presented to indicate basal cytokine elaboration from each cell type. ND, not 
detected. *, p < 0.05 vs. PBS control using Student's t-test.Page 7 of 11
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out the cytoplasm similar to a previous observation in cul-
tured human endometrial cells [35]. Considering more
than 20 h of microscope time and over 30 examined grids,
it was concluded that more than 95% of cells showed
attached M. genitalium organisms with roughly 50% of
cells containing intracellular vacuoles with M. genitalium
collected 0–48 h PI. Importantly, no M. genitalium organ-
isms were ever observed free in the cytosol but were
always bounded by a vacuolar membrane.
Our findings are the first report of intracellular localiza-
tion in cultured human ECs from the vagina, ecto- and
endocervix. These cell types are likely the first target cells
following sexual transmission and therefore acute-phase
interaction and host response are vital to understanding
how M. genitalium establishes reproductive tract infection.
The observation of M. genitalium invasion of vaginal and
cervical ECs (Figure 1 and 2) is consistent with the clinical
observation of heavy intracellular M. genitalium loads in
PCR-positive vaginal specimens [30] and is substantiated
by earlier reports of intracellular localization in cells of
non-reproductive tract origin [27-30]. From our gen-
tamicin invasion studies, M. genitalium was found both at
intracellular sites and in extracellular fractions of infected
cells. These outcomes were consistent with our electron
microscopy studies as well. However, additional investi-
gation will be required to address intracellular M. genital-
ium replication within host reproductive tract ECs as the
experimental systems utilized for our studies did not facil-
itate reliable quantification of this outcome. Interestingly,
it also was observed that, following intracellular localiza-
M. genitalium was phagocytosed rapidly by human monocyte-derived macrophages resulting in a loss of bacterial viabilityFigure 4
M. genitalium was phagocytosed rapidly by human 
monocyte-derived macrophages resulting in a loss of 
bacterial viability. Primary human MDM were inoculated 
with log-phase M. genitalium G37 or M2300 (MOI 100) and 
collected just after inoculation or 30 min or 6 h PI and proc-
essed for TEM. Viable extracellular M. genitalium with dense 
intracellular ribosomes and an intact outer membrane were 
observed at the time of inoculation (A). Thirty minutes fol-
lowing inoculation, phagocytosis of M. genitalium was 
observed with localization to phagolysosomes (arrow) and 
morphological changes of the bacterium (B). By 6 h PI, mac-
rophages contained many phagocytic vacuoles (arrows) and 
no intracellular mycoplasmas could be located (C). Micro-
graphs depict M. genitalium strain G37 but similar findings 
were observed for strain M2300. N denotes nucleus.
Table 2: Cytokine elaboration from human monocyte-derived 
macrophages following exposure to M. genitalium G37a.
Human MDM
Viable UV-Inactivated PBS
IL-1β 31 ± 6.1* 33 ± 1.4* 0.7 ± 0.04
IL-6 385 ± 13.8* 439 ± 4.0* 3.2 ± 0.1
IL-8 5784 ± 149* 5368 ± 564* 116 ± 7.8
G-CSF 63.1 ± 5.5* 72 ± 2.4* 6.2 ± 0.1
IFN-γ 270 ± 24* 339 ± 3.9* 9 ± 3.6
MCP-1 298 ± 9.3* 318 ± 8.3* 36 ± 3.9
MIP-1α 1056 ± 16* 1068 ± 4.0* 176 ± 10.9
MIP-1β 2514 ± 57* 2403 ± 19* 810 ± 47
RANTES 66 ± 1.5* 74 ± 9.9* 11.4 ± 0.4
TNF-α 7456 ± 334* 8616 ± 697* 20 ± 2.0
a Human MDM were inoculated with M. genitalium G37 (MOI 10) or 
an equal volume of the PBS vehicle as a control into triplicate wells. 
Culture supernatants were collected 6 h PI to quantify secreted 
cytokines as described in the Methods. Values are expressed as the 
mean ± SEM pg/mL supernatant. PBS values are presented to indicate 
basal cytokine elaboration. Data collected following exposure to M. 
genitalium strain M2300 were similar in pattern and magnitude. ND, 
not detected. *, p < 0.01 using ANOVA.Page 8 of 11
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cells occurred (Figure 3) from 5–48 h PI suggesting that
periodic egress from infected cells could result in cell to
cell spread. Collectively, these results firmly indicate M.
genitalium's capacity for invasion and prolonged intracel-
lular survival that could provide the organism with a long-
term survival niche in reproductive tract tissues.
From our studies of vaginal and cervical ECs, M. genital-
ium was observed at both intracellular and extracellular
sites. However, it is not clear whether the invasive organ-
isms are genetically different than those that were
observed outside of the cells or whether some unknown
factor facilitates entry of some organisms while excluding
others. In addition, a well-defined tip structure [27,31]
was rarely observed in our studies despite robust attach-
ment to and invasion of the vaginal and cervical ECs (Fig-
ure 1 and 2) used in these studies. An area of increased
electron density was observed within the M. genitalium
organism (Figure 1C, F and 2) adjacent to the host cell sur-
face presumably involved in attachment to the host cell. A
similar structure has been described previously for M. gen-
italium strains grown attached to plastic cultureware [31].
These phenomena suggest that M. genitalium attachment
to and invasion of reproductive tract ECs may not require
a well-defined tip structure. In addition, attachment and
invasion may involve cellular receptors that are localized
to specific membrane sites that are better modeled using
polarized 3-dimensional EC cultures. Indeed, the
observed egress of M. genitalium from infected mucosal
ECs likely would lead to infection of an adjacent cells in
vivo rather than into the culture supernatant of traditional
2-dimensional cultures. This considered, a 3-dimensional
multi-layer model of vaginal EC infection might better
address how M. genitalium interacts with the host mucosa
and establishes primary reproductive tract infection.
Because ECs likely serve as the first responders to STI, we
investigated the acute-phase cytokine response to M. gen-
italium from human vaginal and cervical ECs. We found
that M. genitalium elicited minimal innate responses from
human vaginal ECs from 3 donors but ecto- and endocer-
vical ECs were highly responsive and secreted cytokines
consistent with recruitment of immune cells including IL-
8, G-CSF, GM-CSF and MCP-1 (Table 1). The increased
responsiveness of endocervical ECs may have biological
relevance, as the normally sterile upper tract tissues likely
are more sensitive to microbial contamination than the
lower genital tract. Paradoxically, it is in the upper tract
tissues where inflammation due to microbial infection
likely has the most severe consequences potentially lead-
ing to PID, salpingitis or reduced fertility [36]. Our studies
were focused primarily on the lower genital tract but the
heightened sensitivity of endocervical ECs provides
rationale for testing cell types of the upper tract including
endometrial [35] and fallopian ECs. All of the cell types
used for cytokine analysis were immortalized by transduc-
tion of the human papilloma virus E6/E7 genes known to
reduce the levels, but preserve the pattern of cytokine
secretion relative to primary progenitor cells [16]. There-
fore, we are confident that the observed cytokine induc-
tions indicate the character of the responses but likely
underestimate the actual levels of secretion.
Considering the profile of secreted cytokines by M. genital-
ium-infected reproductive ECs, we next investigated
whether macrophages could play a role in the cellular
immune response to M. genitalium. Following exposure to
human MDM, phagocytosis of M. genitalium occurred rap-
idly (Figure 3) resulting in complete ablation of bacterial
viability by 6 h PI. Importantly, several key pro-inflamma-
tory cytokines were induced in response to M. genitalium
exposure. IL-6 secretion may be of particular importance
considering that IL-6 from vaginal secretions is positively
correlated with HIV-1 burden [14] and known to up-reg-
ulate HIV-1 replication [15]. Indeed, the microbial bur-
den of M. genitalium in clinically-obtained cervical
specimens also is strongly associated with HIV-1 shedding
The M. genitalium-induced inflammatory cytokine secretion from human monocyte-derived acrophages was mediated predomin tely by proteinsFigure 5
The M. genitalium-induced inflammatory cytokine 
secretion from human monocyte-derived macro-
phages was mediated predominately by proteins. 
Human MDM were exposed to viable M. genitalium G37 
(MOI 10) or viable M. genitalium that had been denatured by 
heat or digested with proteinase-K (MOI 10). Cytokine 
secretion was quantified from culture supernatants collected 
6 h following exposure as described in the Methods. Data 
shown are the mean ± SEM of IL-6 (a representative acute-
phase cytokine) induction from a typical experiment using M. 
genitalium strain G37 performed in triplicate wells compared 
to vehicle control (PBS) wells analyzed in parallel for each 
cell type. Data collected for each experiment using strain 
G37 or M2300 were similar in pattern and magnitude 
between 2 additional blood donors. *, p < 0.01 vs. PBS con-
trol using ANOVA. f, p < 0.01 vs. viable M. genitalium G37.Page 9 of 11
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lular reservoirs for latent HIV-1 infection and contribute
to early-stage virus transmission and dissemination
throughout the host (reviewed in [37]). To this end, we
observed significant secretion of 4 potent chemokines
responsible for granulocyte recruitment, MIP1-a, MIP1-b
[38], MCP-1 and RANTES [39] (Table 2) indicating that
macrophage exposure to M. genitalium in reproductive tis-
sues likely would result in significant inflammation con-
sistent with enhanced HIV-1 replication. Our findings
suggest that both infected genital ECs and recruited
immune cells are responsible for secretion of IL-6 and
other cytokines that may contribute to HIV-1 pathogene-
sis but continued research is necessary to dissect the cellu-
lar dynamics of HIV-1 and M. genitalium co-infections.
In our studies, the macrophage-stimulatory capacity of M.
genitalium was not dependent upon bacterial viability.
This outcome likely is due to the highly sensitive nature of
macrophages. However, both heat denaturation and pro-
teinase-K digestion significantly reduced the cytokine
response (Figure 5) suggesting that a large proportion of
M. genitalium's inflammatory capacity is indeed mediated
by protein components. In addition, other findings from
our group showed that M. genitalium and the antigenic
MG309-encoded protein activate TLR2/6 to induce pro-
inflammatory cytokine secretion from human MDM and
reproductive tract ECs [22]. Collectively, these results
indicated that macrophages are highly sensitive to M. gen-
italium exposure and highlight the putative pressure to
evade the cellular immune responses.
Establishment of primary infection and persistence by M.
genitalium in host tissues is not well understood. Our find-
ings suggest that a subset of M. genitalium organisms rap-
idly invade host ECs thereby exploiting an intracellular
survival niche to evade the potent and effective cellular
host immune responses. Studies that address directly
whether reproductive ECs provide protection from macro-
phage phagocytosis are currently underway and will be
essential to understand this mechanism of immune eva-
sion. Importantly, M. genitalium infection resulted in
acute-phase inflammatory cytokine responses from vagi-
nal and cervical ECs. Therefore, it is possible that persist-
ent infection of female reproductive tract tissues may
indeed result in inflammatory outcomes that could affect
reproductive health but continued research is necessary to
fully elucidate the mechanisms of M. genitalium-induced
urogenital disease in women.
Conclusion
Human vaginal, ecto- and endocervical ECs were suscep-
tible to M. genitalium G37 and M2300 infection resulting
in rapid intracellular localization of a subset of organisms
and significant secretion of pro-inflammatory cytokines.
The pattern of cytokine secretion was consistent with
recruitment and stimulation of monocytes and macro-
phages at the vaginal and cervical mucosa. Following
exposure to human monocyte-derived macrophages, M.
genitalium was killed rapidly and elicited a potent pro-
inflammatory response including secretion of cytokines
associated with enhanced HIV-1 replication. These are the
first data showing that cultured human vaginal and cervi-
cal ECs are susceptible and immunologically responsive
to M. genitalium infection likely inducing cellular immune
responses to infected tissues. Continued investigation of
whether intracellular localization in reproductive tract
ECs provides protection from the cellular immune
response is warranted but rapid invasion of vaginal ECs,
combined with the low immunological response, pro-
vides evidence for how M. genitalium might efficiently
establish reproductive tract infection.
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